Statin Therapy for Elderly Patients with Elevated LDL

Patient Assessment and Treatment

The American Diabetes Association recommends continuing the current 40 mg statin dose without intensification for elderly female patients who have already achieved an LDL of 93 mg/dL, which meets the recommended target of <100 mg/dL for moderate-risk patients 1
For elderly patients without diabetes or established atherosclerotic cardiovascular disease (ASCVD), moderate-intensity statin therapy is the appropriate treatment, with a target LDL goal of <100 mg/dL 2, 3, 4, 5
The American College of Cardiology recommends that no dose escalation is needed when LDL is <100 mg/dL in this population 6
For elderly patients with diabetes but without ASCVD, moderate-intensity statin remains appropriate, with a target LDL goal of <100 mg/dL 1, 2, 3
High-intensity statin could be considered if the patient has additional ASCVD risk factors and a calculated 10-year ASCVD risk ≥7.5% 7, 1

For elderly patients with established ASCVD, high-intensity statin therapy should be used, targeting LDL <70 mg/dL with ≥50% reduction from baseline 3, 1
If the patient cannot tolerate high-intensity statin, adding ezetimibe 10 mg daily can achieve an additional 15-20% LDL reduction 8
The American Diabetes Association recommends measuring lipid panel annually once stable target levels are achieved 2, 1
For patients on maximally tolerated statin who don't reach target, a 30-40% LDL reduction from baseline is an acceptable alternative goal 4

The American Heart Association recommends reducing saturated fat to <7% of total calories and dietary cholesterol to <200 mg/day 2, 5
Increasing viscous fiber intake (10-25 g/day) from oats, legumes, and citrus can help lower LDL 2, 5
Adding plant stanols/sterols (2 g/day) can provide additional 5-10% LDL lowering 8
Regular physical activity and weight management if overweight are also recommended 2, 5